The proposed mechanism behind this effect relies upon ADO-mediated down-modulation of chemokine receptors, as intensity of C-X-C chemokine receptor type 4 (CXCR4) levels expressed on CLL is significantly decreased in the CD73+ subset compared to CD73− [2]. Here, ADO is linked to B-cell chronic lymphocytic leukemia.